Your browser doesn't support javascript.
loading
Pre-existing antibody levels negatively correlate with antibody titers after a single dose of BBV152 vaccination.
Das, Suman; Singh, Janmejay; Shaman, Heena; Singh, Balwant; Anantharaj, Anbalagan; Sharanabasava, Patil; Pandey, Rajesh; Lodha, Rakesh; Pandey, Anil Kumar; Medigeshi, Guruprasad R.
Afiliação
  • Das S; Employees State Insurance Corporation Medical College and Hospital, Faridabad, Haryana, India.
  • Singh J; Translational Health Science and Technology Institute, Faridabad, Haryana, India.
  • Shaman H; Translational Health Science and Technology Institute, Faridabad, Haryana, India.
  • Singh B; Translational Health Science and Technology Institute, Faridabad, Haryana, India.
  • Anantharaj A; Translational Health Science and Technology Institute, Faridabad, Haryana, India.
  • Sharanabasava P; Translational Health Science and Technology Institute, Faridabad, Haryana, India.
  • Pandey R; Serum Institute of India, Pune, India.
  • Lodha R; INtegrative GENomics of HOst-PathogEn (INGEN-HOPE) Laboratory, CSIR-Institute of Genomics and Integrative Biology, Delhi, India.
  • Pandey AK; All India Institute of Medical Sciences, New Delhi, India.
  • Medigeshi GR; Employees State Insurance Corporation Medical College and Hospital, Faridabad, Haryana, India.
Nat Commun ; 13(1): 3451, 2022 06 15.
Article em En | MEDLINE | ID: mdl-35705548
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 4_TD Base de dados: MEDLINE Assunto principal: Vacinas Virais / COVID-19 Limite: Humans Idioma: En Revista: Nat Commun Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 4_TD Base de dados: MEDLINE Assunto principal: Vacinas Virais / COVID-19 Limite: Humans Idioma: En Revista: Nat Commun Ano de publicação: 2022 Tipo de documento: Article